Nicotine replacement therapy for smoking cessation during pregnancyDescription
This review provides an overview of current guidelines regarding NRT (nicotine replacement therapy) use in pregnancy, considering the existing evidence base on safety, efﬁcacy and effectiveness.
In addition, it outlines pragmatic suggestions for clinical practice and implications for policy and future research.
Yael Bar-Zeev, Ling Li Lim, Billie Bonevski, Maree Gruppetta, Gillian S Gould
- Develop an understanding of nicotine replacement therapy (NRT), recommended in current Australian clinical guidelines for pregnant women who are unable to quit smoking unassisted
- Become aware of the effects of nicotine on the fetal development in animal models, and the safety and efﬁcacy of nicotine replacement therapy in human studies
- Use this review as a practical guide on how the risks versus beneﬁts of NRT use during pregnancy could be articulated, and how and when to decide whether to use or increase NRT during pregnancy
Nicotine replacement therapy (NRT), guidelines, nicotine, fetal development, pregnancy, smoking cessation
GP, GP Registrar, Specialist, Doctors in Training (DIT), Medical Student, International Medical Graduate, Overseas Trained Doctor, Gynaecologist, Obstetrician